Compare $IMNM vs $SLS | Chartloom

Compare

$IMNM vs $SLS

Immunome Inc · Sellas Life Sciences Group Inc

IMNM

Immunome Inc

SLS

Sellas Life Sciences Group Inc

Compare $IMNM vs $SLS

Comparing Immunome Inc and Sellas Life Sciences Group Inc

IMNMImmunome Inc

SLSSellas Life Sciences Group Inc

IMNMImmunome Inc

Market cap

$2.21B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

127.50x

Rev growth (TTM)

-100.0%

YTD performance

-6.1%

52W performance

39.5%

FCF yield

-10.3%

SLSSellas Life Sciences Group Inc

Market cap

$2.29B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

167.8%

52W performance

503.6%

FCF yield

-1.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMNM

SLS

Detailed metrics comparison

IMNM

Immunome Inc

SLS

Sellas Life Sciences Group Inc

Market Cap

IMNM$2.21B

SLS$2.29B

Enterprise Value

IMNM$2.00B

SLS$2.15B

Price

IMNM$19.55

SLS$11.65

P/E Ratio

IMNMN/A

SLSN/A

P/S Ratio

IMNM188.56x

SLS817.53x

EV/Sales

IMNM171.27x

SLS769.83x

EV/EBITDA

IMNM0.00x

SLS0.00x

P/B Ratio

IMNM4.52x

SLS17.22x

P/FCF Ratio

IMNMN/A

SLSN/A

EV/FCF

IMNM-8.75x

SLS-75.73x

PEG Ratio

IMNMN/A

SLSN/A

Forward P/E (NTM)

IMNMN/A

SLSN/A

Forward P/S (NTM)

IMNM127.50x

SLSN/A

Revenue (TTM)

IMNM$0

SLS$0

Revenue Growth (YoY)

IMNM-100.0%

SLSN/A

Forward Rev Growth

IMNM15247.2%

SLS144.9%

Gross Margin (TTM)

IMNM0.0%

SLS93.1%

Operating Margin (TTM)

IMNM0.0%

SLS0.0%

EBITDA Margin (TTM)

IMNM0.0%

SLS0.0%

Net Margin (TTM)

IMNM0.0%

SLS0.0%

FCF Margin (TTM)

IMNMN/A

SLSN/A

Net Income (TTM)

IMNM$-254M

SLS$-32M

FCF (TTM)

IMNM$-228M

SLS$-28M

EPS (TTM)

IMNM-$2.25

SLS-$0.17

ROE (TTM)

IMNM-5056.0%

SLS-3591.0%

ROA (TTM)

IMNM-4693.0%

SLS-3334.0%

ROIC (TTM)

IMNM-5056.0%

SLS-3591.0%

Cash

IMNM$218M

SLS$138M

Debt

IMNM$0

SLS$0

Net Cash/Debt

IMNM$218M

SLS$138M

Current Ratio (TTM)

IMNM15.08x

SLS18.83x

Quick Ratio (TTM)

IMNM14.56x

SLS18.29x

Debt/Equity (TTM)

IMNM0.00x

SLS0.00x

Debt/Assets (TTM)

IMNM0.0%

SLS0.0%

Interest Coverage (TTM)

IMNMN/A

SLSN/A

Net Debt/EBITDA (TTM)

IMNM0.00x

SLS0.00x

Beta

IMNM2.65

SLS2.68

52W Performance

IMNM39.5%

SLS503.6%

YTD Performance

IMNM-6.1%

SLS167.8%

% from 52W High

IMNM-35.0%

SLS-26.6%

% from 52W Low

IMNM44.9%

SLS738.1%

Asset Turnover (TTM)

IMNM0.04x

SLS0.09x

FCF Yield (TTM)

IMNM-10.3%

SLS-1.2%

Earnings Yield (TTM)

IMNM-11.5%

SLS-1.4%

Dividend Yield (TTM)

IMNMN/A

SLSN/A

Rule of 40

IMNM-100.0

SLS0.0

EV/GP/RG

IMNMN/A

SLSN/A

Ticker research

View IMNM research View SLS research

Metric	IMNM Immunome Inc	SLS Sellas Life Sciences Group Inc
Market & Valuation
Market Cap	$2.21B	$2.29B
Enterprise Value	$2.00B	$2.15B
Price	$19.55	$11.65
P/E Ratio	N/A	N/A
P/S Ratio	188.56x	817.53x
EV/Sales	171.27x	769.83x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.52x	17.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.75x	-75.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	127.50x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	15247.2%	144.9%
Profitability
Gross Margin (TTM)	0.0%	93.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-254M	$-32M
FCF (TTM)	$-228M	$-28M
EPS (TTM)	-$2.25	-$0.17
ROE (TTM)	-5056.0%	-3591.0%
ROA (TTM)	-4693.0%	-3334.0%
ROIC (TTM)	-5056.0%	-3591.0%
Financial Health
Cash	$218M	$138M
Debt	$0	$0
Net Cash/Debt	$218M	$138M
Current Ratio (TTM)	15.08x	18.83x
Quick Ratio (TTM)	14.56x	18.29x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.65	2.68
52W Performance	39.5%	503.6%
YTD Performance	-6.1%	167.8%
% from 52W High	-35.0%	-26.6%
% from 52W Low	44.9%	738.1%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.09x
FCF Yield (TTM)	-10.3%	-1.2%
Earnings Yield (TTM)	-11.5%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMNM research	View SLS research

Valuation

P/S Ratio

IMNM

188.56x

SLS

817.53x

EV/FCF

SLS

-75.73x

IMNM

-8.75x

Growth & revenue

Revenue Growth TTM

IMNM

-100.0%

Forward Revenue Growth

IMNM

15247.2%

SLS

144.9%

Profitability & performance

Gross Margin

SLS

93.1%

IMNM

0.0%

ROE

SLS

-3591.0%

IMNM

-5056.0%

FCF Yield %

SLS

-1.2%

IMNM

-10.3%

52-Week Performance

SLS

503.6%

IMNM

39.5%

Detailed metrics comparison

IMNM

Immunome Inc

SLS

Sellas Life Sciences Group Inc

Market Cap

IMNM$2.21B

SLS$2.29B

Enterprise Value

IMNM$2.00B

SLS$2.15B

Price

IMNM$19.55

SLS$11.65

P/E Ratio

IMNMN/A

SLSN/A

P/S Ratio

IMNM188.56x

SLS817.53x

EV/Sales

IMNM171.27x

SLS769.83x

EV/EBITDA

IMNM0.00x

SLS0.00x

P/B Ratio

IMNM4.52x

SLS17.22x

P/FCF Ratio

IMNMN/A

SLSN/A

EV/FCF

IMNM-8.75x

SLS-75.73x

PEG Ratio

IMNMN/A

SLSN/A

Forward P/E (NTM)

IMNMN/A

SLSN/A

Forward P/S (NTM)

IMNM127.50x

SLSN/A

Revenue (TTM)

IMNM$0

SLS$0

Revenue Growth (YoY)

IMNM-100.0%

SLSN/A

Forward Rev Growth

IMNM15247.2%

SLS144.9%

Gross Margin (TTM)

IMNM0.0%

SLS93.1%

Operating Margin (TTM)

IMNM0.0%

SLS0.0%

EBITDA Margin (TTM)

IMNM0.0%

SLS0.0%

Net Margin (TTM)

IMNM0.0%

SLS0.0%

FCF Margin (TTM)

IMNMN/A

SLSN/A

Net Income (TTM)

IMNM$-254M

SLS$-32M

FCF (TTM)

IMNM$-228M

SLS$-28M

EPS (TTM)

IMNM-$2.25

SLS-$0.17

ROE (TTM)

IMNM-5056.0%

SLS-3591.0%

ROA (TTM)

IMNM-4693.0%

SLS-3334.0%

ROIC (TTM)

IMNM-5056.0%

SLS-3591.0%

Cash

IMNM$218M

SLS$138M

Debt

IMNM$0

SLS$0

Net Cash/Debt

IMNM$218M

SLS$138M

Current Ratio (TTM)

IMNM15.08x

SLS18.83x

Quick Ratio (TTM)

IMNM14.56x

SLS18.29x

Debt/Equity (TTM)

IMNM0.00x

SLS0.00x

Debt/Assets (TTM)

IMNM0.0%

SLS0.0%

Interest Coverage (TTM)

IMNMN/A

SLSN/A

Net Debt/EBITDA (TTM)

IMNM0.00x

SLS0.00x

Beta

IMNM2.65

SLS2.68

52W Performance

IMNM39.5%

SLS503.6%

YTD Performance

IMNM-6.1%

SLS167.8%

% from 52W High

IMNM-35.0%

SLS-26.6%

% from 52W Low

IMNM44.9%

SLS738.1%

Asset Turnover (TTM)

IMNM0.04x

SLS0.09x

FCF Yield (TTM)

IMNM-10.3%

SLS-1.2%

Earnings Yield (TTM)

IMNM-11.5%

SLS-1.4%

Dividend Yield (TTM)

IMNMN/A

SLSN/A

Rule of 40

IMNM-100.0

SLS0.0

EV/GP/RG

IMNMN/A

SLSN/A

Ticker research

View IMNM research View SLS research

Metric	IMNM Immunome Inc	SLS Sellas Life Sciences Group Inc
Market & Valuation
Market Cap	$2.21B	$2.29B
Enterprise Value	$2.00B	$2.15B
Price	$19.55	$11.65
P/E Ratio	N/A	N/A
P/S Ratio	188.56x	817.53x
EV/Sales	171.27x	769.83x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.52x	17.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.75x	-75.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	127.50x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	15247.2%	144.9%
Profitability
Gross Margin (TTM)	0.0%	93.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-254M	$-32M
FCF (TTM)	$-228M	$-28M
EPS (TTM)	-$2.25	-$0.17
ROE (TTM)	-5056.0%	-3591.0%
ROA (TTM)	-4693.0%	-3334.0%
ROIC (TTM)	-5056.0%	-3591.0%
Financial Health
Cash	$218M	$138M
Debt	$0	$0
Net Cash/Debt	$218M	$138M
Current Ratio (TTM)	15.08x	18.83x
Quick Ratio (TTM)	14.56x	18.29x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.65	2.68
52W Performance	39.5%	503.6%
YTD Performance	-6.1%	167.8%
% from 52W High	-35.0%	-26.6%
% from 52W Low	44.9%	738.1%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.09x
FCF Yield (TTM)	-10.3%	-1.2%
Earnings Yield (TTM)	-11.5%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMNM research	View SLS research